SANUWAVE Health, Inc. SNWV
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.36% | 22.21% | 34.62% | 40.48% | 56.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.36% | 22.21% | 34.62% | 40.48% | 56.95% |
| Cost of Revenue | 19.21% | 21.92% | 24.72% | 12.78% | 23.53% |
| Gross Profit | 10.39% | 22.30% | 37.88% | 50.81% | 70.23% |
| SG&A Expenses | 25.46% | 42.15% | 46.73% | 52.90% | 49.07% |
| Depreciation & Amortization | 27.49% | 16.90% | 11.53% | 6.87% | 7.45% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.95% | 38.27% | 40.52% | 38.51% | 38.87% |
| Operating Income | -65.54% | -43.93% | 5.00% | 53.23% | 349.24% |
| Income Before Tax | 135.43% | 145.12% | 133.13% | -2,412.73% | -1,086.00% |
| Income Tax Expenses | 240.74% | 218.52% | 218.52% | 575.00% | 575.00% |
| Earnings from Continuing Operations | 135.18% | 144.84% | 132.85% | -2,393.83% | -1,085.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 135.18% | 144.84% | 132.85% | -2,393.83% | -1,085.40% |
| EBIT | -65.54% | -43.93% | 5.00% | 53.23% | 349.24% |
| EBITDA | -52.88% | -36.66% | 7.37% | 44.78% | 209.72% |
| EPS Basic | 118.86% | 126.53% | 116.69% | -638.74% | -172.21% |
| Normalized Basic EPS | 114.94% | 117.14% | 110.07% | -33.37% | -85.55% |
| EPS Diluted | 102.63% | 103.75% | 96.46% | -1,917.68% | -151.75% |
| Normalized Diluted EPS | 114.21% | 116.23% | 109.26% | -31.33% | -83.44% |
| Average Basic Shares Outstanding | 19.61% | 47.20% | 91.89% | 174.15% | 146.81% |
| Average Diluted Shares Outstanding | 19.83% | 49.69% | 93.78% | 171.66% | 140.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |